Skip to search formSkip to main contentSkip to account menu

Piribedil

Known as: Piribedil [Chemical/Ingredient], Piribendyl, Pyrimidine, 2-(4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl)- 
A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for… 
National Institutes of Health

Related topics

Related topics

13 relations

Broader (2)

Antiparkinson AgentsDopamine Agonists

Narrower (4)

ET-495Piribedil HydrochloridePiribedil MesylateTrivastal
In Bloodagonistsanalogs & derivativesantagonists & inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2006
Review
2006
Proposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson's disease: a review of the literature.
Highly Cited
1999
Highly Cited
1999
Neurochemical evidence of dopamine release by lateral olivocochlear efferents and its presynaptic modulation in guinea-pig cochlea
Highly Cited
1983
Highly Cited
1983
Pharmacological characteristics of dopamine receptors involved in the dual effect of dopamine agonists on yawning behaviour in rats.
1983
1983
Uptake and release of [3H]dopamine by the median eminence: Evidence for presynaptic dopaminergic receptors and for dopaminergic feedback inhibition
1982
1982
Behavioural and biochemical changes following chronic administration of L-dopa to rats.
1981
1981
Differential effects of certain dopaminergic drugs on the striatal concentration of dopamine metabolites, with special reference to 3-methoxytyramine
Highly Cited
1980
Highly Cited
1980
Accumulation of L-dopa in the median eminence: an index of tuberoinfundibular dopaminergic nerve activity.
A microradioenzymatic assay for dihydroxyphenylalanine (dopa) was used to measure the concentration of this precursor of dopamine… 
Highly Cited
1979
Highly Cited
1979
Interaction between opiates and hypothalamic dopamine on prolactin release.
Highly Cited
1978
Highly Cited
1978
Chemical lesion and drug induced supersensitivity and subsensitivity of caudate dopamine receptors.
1978
1978
Rotation produced by administration of dopamine and related substances directly into the supersensitive caudate nucleus.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)